Fiche du document
2013
- doi: 10.1177/2050640613487194
- issn: 2050-6406
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1177/2050640613487194
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/24917961
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/2050-6406
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_399FB3B593284
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Sujets proches
AdministrationCiter ce document
K. Gecse et al., « Fistulizing Crohn's disease: Diagnosis and management. », Serveur académique Lausannois, ID : 10.1177/2050640613487194
Métriques
Partage / Export
Résumé
Fistulizing Crohn's disease represents an evolving, yet unresolved, issue for multidisciplinary management. Perianal fistulas are the most frequent findings in fistulizing Crohn's disease. While enterocutaneous fistulas are rare, they are associated with considerable morbidity and mortality. Detailed evaluation of the fistula tract by advanced imaging techniques is required to determine the most suitable management options. The fundamentals of perianal fistula management are to evaluate the complexity of the fistula tract, and exclude proctitis and associated abscess. The main goals of the treatment are abscess drainage, which is mandatory, before initiating immunosuppressive medical therapy, resolution of fistula discharge, preservation of continence and, in the long term, avoidance of proctectomy with permanent stoma. The management of enterocutaneous fistulas comprises of sepsis control, skin care, nutritional optimization and, if needed, delayed surgery.